<法規>
<法規性質>命令</法規性質>
<英文法規名稱>Regulations for Application of Health Food Permit</英文法規名稱>
<中文法規名稱>健康食品申請許可辦法</中文法規名稱>
<法規網址>http://law.moj.gov.tw/Eng/LawClass/LawContent.aspx?PCODE=L0040030</法規網址>
<最新英文異動日期>20160121</最新英文異動日期>
<廢止註記>
</廢止註記>
<附件 />
<沿革內容><![CDATA[1.20 Articles promulgated by DOH Food, Order No. 88035438 on 29 May 1999.
2.Amendment to Article 1, 2, 2-1, 2-2, 3, 4, 11, 12, 13, promulgated by DOH, Order No. 0950408514 on 30 October 2006.
3.Amendment to Article 2, 2-1, 17. 20, promulgated by DOH, Order No. 1011302400 on 29 August 2012
4.Amendment to Article 4 and 8, promulgated by MOHW, Order No. 1021352122 on 28 January 2014
5.Amendment to Articles 2, 2-1, 3, 4, 6, 7, 8, and 13, promulgated by MOHW, Order No. 1041304070 on 21 January 2016]]></沿革內容>
<前言><![CDATA[]]></前言>
<法規內容>
  <條文>
    <條號>Article 1</條號>
    <條文內容><![CDATA[These Regulations are set forth pursuant to the paragraph 5 of Article 7 of the Health Food Control Act (hereinafter referred to as "Act").
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 2</條號>
    <條文內容><![CDATA[All applications filed for product registration under subparagraph 1, paragraph 1 of Article 3 of the Act shall be accompanied by the preliminary review fee, intact product samples, and following documents and information:
(1) Application form
(2) Specifications and quantity of ingredients
(3) Safety assessment report
(4) Health care effect assessment report
(5) Identification report on ingredients with health care effect of a product and its examination method employed
(6) Test report on the ingredient stability of a product and its health care effect
(7) Summary of manufacturing process
(8) Documentary evidence of good manufacturing practices
(9) Sanitary specifications and its test report
(10) General nutrients analysis report
(11) Relevant research reports and literatures
(12) Product package, label and information leaflet
(13) Registration certificate of the applicant's corporation or business
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 2-1</條號>
    <條文內容><![CDATA[All applications filed for product registration under subparagraph 2, paragraph 1 of Article 3 of the Act shall be accompanied by the preliminary review fee, intact product samples, and following documents and information:
(1) Application form
(2) Specifications of the raw materials and quantity of ingredients of the product
(3) Ingredients specification test report of a product
(4) Test report on the ingredient stability of a product and its health care effect
(5) Summary of manufacturing process
(6) Documentary evidence of good manufacturing practices
(7) Sanitary specifications and its test report
(8) General nutrients analysis report
(9) Package, label and product instruction sheet
(10) Certificate of the applicant's corporation or business registration
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 2-2</條號>
    <條文內容><![CDATA[The application by the subparagraph 1 or 2, paragraph 1 of Article 3 of the Act to the central competent health authority for product registration, the authority just accept one product for one health care effect or one specification per case. It will be issued one license after permitting.
The products had have health food license could be added health care effect items; they should be applied as the change license registration to the central competent health authority.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 3</條號>
    <條文內容><![CDATA[The above application shall be subject to the preliminary review by the central competent health authority in terms of the completeness of the documents and information submitted, particulars of the applicant, package, label and instruction sheet of the product, general consumption safety of ingredients of the product etc.
If the application information submitted for preliminary review is incomplete, the necessary documents and information shall be submitted within two months after the notice of the central competent health authority. The applicant may apply for one-month extension when necessary. Failure to submit the complete documents and information within the prescribed deadline will result in the rejection of the application.
If an application by the paragraph 1 of Article 3 of the Act is accepted after preliminary review, the applicant shall pay the secondary review fee within one month from the day following the date on which the preliminary review notice is served, and submit copies of complete documents and information described in Article 2 or the preceding article to the central competent health authority; number of copies required for submission is specified in the notice. Failure to pay the secondary review fee or submit the missing documents and information within the prescribed deadline will result in the rejection of the application.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 4</條號>
    <條文內容><![CDATA[If an application by the subparagraph 1, paragraph 1 of Article 3 of the Act is deemed to have met all requirements after preliminary review, the health food review committee of the central competent health authority shall review the application documents and information in terms of the safety, health care effect, package, label and instruction sheet of the product, and provide its review opinion on the application to the central competent health authority.
If an application by the subparagraph 2, paragraph 1 of Article 3 of the Act is deemed to have met all requirements after preliminary review, unless require, it shall not be submitted to the health food review committee of the central competent health authority for secondary review, but this authority could ask for product verification.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 5</條號>
    <條文內容><![CDATA[Upon completing review of an application in accordance with the above opinion and applicable laws and regulations, the central competent health authority shall notify the applicant that the application is rejected or accepted, or request the applicant to submit further necessary information or samples for verification, as the case may be.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 6</條號>
    <條文內容><![CDATA[If an applicant is requested to submit further necessary information after secondary review of its application, the information being requested shall be submitted within two months after the notice of the central competent health authority. The applicant may apply for one-month extension when necessary. Failure to submit the complete information within the prescribed deadline will result in the rejection of the application.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 7</條號>
    <條文內容><![CDATA[If an applicant is requested to submit samples for verification after review of its application, sufficient original, intact samples for examination shall be submitted along with an examination fee to an analysis institution designated by the central competent health authority in accordance with the contents of the notice of said authority within one month of such notice. Results of the examination shall serve as reference for the above authority to rely on in granting approval. Failure to pay the examination fee or submit the samples within the prescribed period will result in the rejection of the application.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 8</條號>
    <條文內容><![CDATA[If an application is accepted, the central competent health authority shall issue an approval in writing upon payment of a permit fee by the applicant. The approval shall be valid for five years and extendable within three months prior to expiration. The original approval shall automatically become invalid if no application for extension is filed within the prescribed period or such application is not accepted.
In case of failure to file a permit extension application before the permit expiration date, the permit holder may re-apply for inspection and registration within six months following the permit expiration date. The re-application shall be accompanied by the intact samples and following documents, information, and the applicant shall pay the fees according to the related provisions of the Regulations:  
(1) Application form
(2) Specifications and quantity of ingredients 
(3) Identification report on ingredients with health care effect of a product and its examination method employed
(4) Summary of manufacturing process
(5) Documentary evidence of good manufacturing practices
(6) Sanitary specifications and its test report
(7) General nutrients analysis report
(8) Product package, label and information leaflet
(9) Registration certificate of the applicant's corporation or business
(10) Original copy of issued permit
For official permits issued pursuant by the subparagraph 1, paragraph 1 of Article 3, upon require, the central competent health authority may further require the attachment of the product safety assessment report, health care effect assessment report, test report on the stability of health care effect and relevant research reports and literatures.
For official permits issued pursuant by the subparagraph 2, paragraph 1 of Article 3, upon require, the central competent health authority may further require the attachment of the product health care effect stability test report.
For renewed inspection and registration applications filed pursuant to subparagraph 2, unless require, it shall not be submitted to the health food review committee of the central competent health authority for secondary review or to submit product for inspection and verification.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 9</條號>
    <條文內容><![CDATA[The specifications of the raw materials and quantity of ingredients shall be reviewed mainly in terms of the following aspects:
(1) Such ingredients shall be harmless to human health and safety without including any of those described in Article 12 of the Act.
(2) Information on such specifications and quantity shall consist of the detailed name and contents of all raw materials and food additives.
(3) The scope and application of food additives shall conform to regulations promulgated by the central competent health authority.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 10</條號>
    <條文內容><![CDATA[The safety assessment report shall be reviewed mainly in terms of the following aspects:
(1) Safety assessment tests shall be conducted in accordance with the Guidelines of Health Food Safety Assessment promulgated by the central competent health authority. The assessment report shall be accomplished by information as required by the Guidelines.
(2) Information on toxicity test may be exempted under any of the following circumstances:
a. The raw materials of the product are conventionally consumed and the product is in the form of commonly processed food; or
b. There are complete academic literature and reports on the toxicology and safety, as well as records of consumption, of the product; and the raw materials, components and manufacturing process of the product are consistent in every aspect with those mentioned in the above academic literature and reports.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 11</條號>
    <條文內容><![CDATA[The health care effect assessment report shall be reviewed mainly in terms of the following aspects:
(1) Pursuant to subparagraph 2 of the first paragraph of Article 3 of the Act, health care effect shall be harmless, definite and steady as duly supported by scientific assessment and test or by academic principles.
(2) Pursuant to subparagraph 3 of the first paragraph of Article 3 of the Act, the reasonable intake of the product shall be supported by scientific evidences.
(3) Health care effect assessment and test shall be conducted in accordance with the Guidelines of Health Food Health Care Effect Assessment promulgated by the central competent health authority, otherwise, supporting scientific evidence of the test adopted shall be submitted for verification of the accuracy of such test.
The certificate of ingredients specification shall be reviewed mainly in if conform the specification for health food by the central competent health authority or not.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 12</條號>
    <條文內容><![CDATA[The identification report on ingredients with health care effect and method of examination shall be reviewed mainly in terms of the following aspects:
(1) The product shall contain ingredients with definite health care effect pursuant to the subparagraph 1, paragraph 1 of Article 3 of the Act.
(2) The identification report shall include results of qualitative and quantitative tests on the above ingredients.
(3) The method of examination shall be generally recognized as scientifically reliable and accurate.
(4) With respect to ingredients with health care effect which cannot be identified by existing technology, information on the ingredients carrying such effect or the relevant supporting literature shall be submitted.
The ingredients specification test report shall be reviewed mainly in if conform the specification for health food by the central competent health authority or not.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 13</條號>
    <條文內容><![CDATA[The focal points of the review conducted on the test report on the ingredient stability of a product and its health care effect are as follows:
(1) Such report shall serve as the basis to review the shelf life of the health care effect.
(2) Such report shall consist of the testing method, data and results with respect to at least three lots of samples.
(3) The application by the subparagraph 1, paragraph 1 of Article 3 of the Act, the representative characteristics of the efficacy ingredient shall be adopted as the testing criteria in the stability test. Where existing technology cannot identify ingredients with health care effect, items listed in the Guidelines of Health Food Health Care Effect Assessment shall serve as such criteria.
(4) The application by the subparagraph 2, paragraph 1 of Article 3 of the Act, the representative characteristics of the efficacy ingredient shall conform the specification for health food in the stability test.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 14</條號>
    <條文內容><![CDATA[The summary of manufacturing process shall be reviewed mainly in terms of the following aspects:
(1) The summary shall include the preparation and processing procedures of the raw materials, and conditions of processing.
(2) In case of extraction, the method of extraction and name of the solvent shall be provided; in case of concentration, the multiples shall be provided.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 15</條號>
    <條文內容><![CDATA[The supporting document of good manufacturing practices shall be reviewed in terms of mainly in the following aspects:
(1) In case of domestic products, information on control of the manufacturing process shall be submitted in accordance with the good manufacturing practices regulations enacted by the central competent health authority. Where necessary, the central competent health authority may perform the on-side inspection of the manufacturer's premises.
(2) In case of imported products, the full text of the good manufacturing practices regulations of the country of origin, quality control plan, and official certificate of compliance with such regulations shall be submitted.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 16</條號>
    <條文內容><![CDATA[The sanitary specifications and its test report shall be reviewed mainly in terms of the following aspects:
(1) Such specifications shall conform to Articles 11 and 12 of the Act.
(2) At least three lots of samples shall be examined.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 17</條號>
    <條文內容><![CDATA[The review of the general nutrients analysis report shall be focused as follows:
(1) The nutrients analysis shall include at least the requirements for health food and product nutrients labeling regulations.
(2) At least three lots of samples shall be examined.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 18</條號>
    <條文內容><![CDATA[The relevant research reports and literature shall be reviewed mainly in terms of the following aspects:
Literature and information that are submitted on research and application of similar products at home and abroad shall be generally recognized as scientifically reliable and accurate.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 19</條號>
    <條文內容><![CDATA[The package, label and product instruction sheet shall be reviewed mainly in terms of the following aspects:
(1) The container, package and instruction sheet of the product shall contain material facts as specified in Articles 13 and 14 of the Act.
(2) The descriptions of health care effect being submitted for review shall correspond with the assessment results; the contents thereof shall be true and not be misleading.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 20</條號>
    <條文內容><![CDATA[The Regulation shall be enforced as of the enforcement of the Act.
The amendatory clauses of the Regulation shall be enforced as of the enforcement of the Act.
]]></條文內容>
  </條文>
</法規內容>
</法規>
